Form 4: Alphatec Holdings Director Bakst Receives Restricted Stock Units, Disposes of Shares Held in Trust

Director Evan Bakst received 16,747 restricted stock units from Alphatec Holdings and disposed of 15,000 shares held by The DEB Children's Trust.

Summary

• On June 12, 2024, Alphatec Holdings granted director Evan Bakst 16,747 restricted stock units (RSUs).
• Each RSU represents a contingent right to receive one share of Alphatec Holdings' common stock.
• The RSUs vest on the earlier of the next annual meeting of stockholders or the death or resignation of the reporting person, with pro-rata vesting in case of death or resignation.
• Bakst also disposed of 15,000 shares held indirectly by The DEB Children's Trust.
• Following these transactions, Bakst beneficially owns 1,105,785 shares of Alphatec Holdings' common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It reflects standard executive compensation practices and insider trading disclosures. The RSU grant is a positive sign of aligning interests, while the disposal of shares is a neutral event that requires further context.

Positives

• The grant of restricted stock units aligns the director's interests with those of the shareholders.

Negatives

• The disposal of 15,000 shares held by The DEB Children's Trust could be interpreted negatively by some investors, although it may be for personal financial planning reasons.

Risks

• The vesting of the RSUs is contingent upon future events, including the director's continued service or the occurrence of the next annual meeting.
• The pro-rata vesting in case of death or resignation introduces uncertainty regarding the ultimate number of shares that will be issued.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting conditions of the restricted stock units.

Industry Context

This filing is a routine disclosure related to executive compensation and stock ownership, common in the healthcare and medical device industry. It provides transparency into the alignment of management's interests with shareholders.

Comparison to Industry Standards

• Restricted stock units are a common form of executive compensation in the medical device industry, used by companies like Medtronic, Stryker, and Johnson & Johnson to incentivize and retain key personnel.
• The vesting schedules and terms are generally comparable to industry norms, often tied to continued employment or achievement of specific performance milestones.
• The size of the RSU grant is likely determined based on the director's role, responsibilities, and overall compensation package, benchmarked against peer companies.

Stakeholder Impact

• The RSU grant could positively impact shareholders by aligning the director's interests with the company's long-term success.
• The disposal of shares by The DEB Children's Trust may have a negligible impact on stakeholders.

Key Dates